The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer.
AuthorsEllis, J R
Keating, P J
Hounsell, E F
Renouf, D V
Duggan-Keen, Margaret F
Bartholomew, J S
Young, L S
Stern, Peter L
AffiliationUniversity of Birmingham CRC Institute for Cancer Studies, University of Birmingham Medical School, UK.
MetadataShow full item record
AbstractHLA-restricted cytotoxic T-lymphocyte (CTL) recognition of human papillomavirus (HPV) oncogene products may be important in the control of the HPV infections associated with the development of cervical cancer. We have identified, in HLA-B7 individuals, a consistent variation in the HPV16 E6 oncoprotein sequence, which alters an HLA-B7 peptide binding epitope in a way likely to influence immune recognition by CTLs. These results illustrate a biologically relevant mechanism for escape from immune surveillance of HPV16 in HLA-B7 individuals. Thus, both HLA type and HPV16 strain variation need to be considered in the screening of at-risk individuals and for the rational design of anti-HPV vaccines.
CitationThe association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. 1995, 1 (5):464-70 Nat. Med.
- Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
- Authors: Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM
- Issue date: 1995 Jun 1
- Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.
- Authors: Evans M, Borysiewicz LK, Evans AS, Rowe M, Jones M, Gileadi U, Cerundolo V, Man S
- Issue date: 2001 Nov 1
- Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses.
- Authors: Mizuuchi M, Hirohashi Y, Torigoe T, Kuroda T, Yasuda K, Shimizu Y, Saito T, Sato N
- Issue date: 2012 Feb
- HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions.
- Authors: Evans C, Bauer S, Grubert T, Brucker C, Baur S, Heeg K, Wagner H, Lipford GB
- Issue date: 1996 Mar
- T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
- Authors: Azoury-Ziadeh R, Herd K, Fernando GJ, Frazer IH, Tindle RW
- Issue date: 1999